These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23738491)

  • 1. Painful side effects. Drug-abuse problems evade paltry anti-fraud efforts in Medicare Part D.
    Carlson J
    Mod Healthc; 2013 Apr; 43(15):32-3. PubMed ID: 23738491
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
    [No Abstract]   [Full Text] [Related]  

  • 3. Unnecessary compromise. Slow national drug traceability efforts cut down states' faster efforts.
    Goozner M
    Mod Healthc; 2013 Jun; 43(23):18. PubMed ID: 24199354
    [No Abstract]   [Full Text] [Related]  

  • 4. Part D in crosshairs for 2009.
    Liethen J; Bakewicz J
    Manag Care; 2009 Aug; 18(8):52-4. PubMed ID: 19731512
    [No Abstract]   [Full Text] [Related]  

  • 5. The supercharged federal effort to crack down on fraud and abuse.
    Iglehart JK
    Health Aff (Millwood); 2010 Jun; 29(6):1093-5. PubMed ID: 20530335
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicaid program integrity: fighting fraud, waste, and abuse.
    Comlossy M
    NCSL Legisbrief; 2013 Feb; 21(7):1-2. PubMed ID: 23581027
    [No Abstract]   [Full Text] [Related]  

  • 7. Enforcement, investigation, prosecution.
    Provider; 2010 Feb; 36(2):30, 32. PubMed ID: 20183972
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals and Medical Devices: Medicare Part D.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-31. PubMed ID: 27116795
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare program; revisions to the Medicare Advantage and Part D prescription drug contract determinations, appeals, and intermediate sanctions processes. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Dec; 72(233):68699-741. PubMed ID: 18064773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; application of certain appeals provisions to the Medicare prescription drug appeals process. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2009 Dec; 74(235):65339-78. PubMed ID: 20169677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fraud prosecutions up 69%: shift in investigators' tactics, evolution in technology seen as reasons.
    Carlson J
    Mod Healthc; 2012 Jan; 42(2):14-5. PubMed ID: 22299221
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-28. PubMed ID: 21374839
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription opioid forgery: reporting to law enforcement and protection of medical information.
    Singh N; Fishman S; Rich B; Orlowski A
    Pain Med; 2013 Jun; 14(6):792-8. PubMed ID: 23461809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding money for health care reform--rooting out waste, fraud, and abuse.
    Iglehart JK
    N Engl J Med; 2009 Jul; 361(3):229-31. PubMed ID: 19516025
    [No Abstract]   [Full Text] [Related]  

  • 16. Fraud and abuse compliance programs: their time has come.
    DeMuro PR; Roth JC
    Healthc Financ Manage; 1993 Mar; 47(3):50-2, 54, 56. PubMed ID: 10145769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-fraud enforcement on Medicare costs and quality.
    Natl Bur Econ Res Bull Aging Health; 2004; (9):3. PubMed ID: 15580713
    [No Abstract]   [Full Text] [Related]  

  • 18. 2010 outlook. Legal: enforcement ahead.
    Blesch G
    Mod Healthc; 2010 Jan; 40(1):28. PubMed ID: 20091994
    [No Abstract]   [Full Text] [Related]  

  • 19. The fault lies not in the stars..
    Campo DG
    Del Med J; 2011 Nov; 83(11):361-3. PubMed ID: 22372122
    [No Abstract]   [Full Text] [Related]  

  • 20. Time to fill the doughnuts--health care reform and Medicare Part D.
    Shrank WH; Choudhry NK
    N Engl J Med; 2011 Feb; 364(7):598-601. PubMed ID: 21247308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.